PLUS1
Period:
Draw Mode:
| Volume | 117,353 |
|
|||||
| News | - | ||||||
| Day High | 15.10 | Low High |
|||||
| Day Low | 14.21 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Kala Pharmaceuticals Inc | KALA | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| 0.45 | 3.08% | 15.05 | 10:15:13 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 14.86 | 14.21 | 15.10 | 15.05 | 14.60 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,523 | 117,353 | US$ 14.61 | US$ 1,714,619 | - | 3.5444 - 74.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 10:15:13 | 50 | US$ 14.95 | USD |
Kala Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 843.70M | 56.06M | 1.90M | US$ 3.89M | US$ - | -30.27 | -0.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 66.20% |
Kala Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 29/3/2023 | 23:00 | GlobeNewswire Inc. | Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief.. |
| 27/3/2023 | 23:08 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 27/3/2023 | 23:00 | GlobeNewswire Inc. | Kala Pharmaceuticals Announces Positive Safety Update from.. |
| 15/3/2023 | 21:43 | Edgar (US Regulatory) | Notice of Effectiveness (effect) |
| 14/3/2023 | 07:04 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 09/3/2023 | 08:01 | GlobeNewswire Inc. | Kala Pharmaceuticals to Present at the Oppenheimer 33rd.. |
| 04/3/2023 | 08:13 | Edgar (US Regulatory) | Securities Registration Statement (simplified Form) (s-3) |
| 04/3/2023 | 00:17 | Edgar (US Regulatory) | Annual Report (10-k) |
| 04/3/2023 | 00:06 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 04/3/2023 | 00:00 | GlobeNewswire Inc. | Kala Pharmaceuticals Reports Fourth Quarter and Full Year.. |
| 02/3/2023 | 08:37 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting.. |
| 15/2/2023 | 08:39 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) |
Historical KALA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.29 | 18.35 | 13.90 | 15.16 | 333,463 | 0.76 | 5.32% |
| 1 Month | 10.68 | 24.00 | 10.21 | 18.96 | 1,856,241 | 4.37 | 40.92% |
| 3 Months | 34.37 | 36.3818 | 9.3612 | 19.43 | 1,023,781 | -19.32 | -56.21% |
| 6 Months | 11.25 | 56.7199 | 3.5444 | 21.04 | 1,655,919 | 3.80 | 33.78% |
| 1 Year | 71.00 | 74.00 | 3.5444 | 21.61 | 1,539,935 | -55.95 | -78.8% |
| 3 Years | 371.50 | 734.00 | 3.5444 | 204.86 | 1,614,137 | -356.45 | -95.95% |
| 5 Years | 788.50 | 903.50 | 3.5444 | 225.01 | 1,124,093 | -773.45 | -98.09% |